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DObjective: The goal of this study was to examine the feasibility, acceptability, and efficacy of a brief, tailored
cognitive–behavioral intervention for patients with symptoms of preoperative depression or anxiety before un-
dergoing a coronary artery bypass graft (CABG) operation.
Methods: Patients were recruited from a university teaching hospital between February 2007 and May 2009.
Patients were randomly assigned to receive treatment as usual (TAU) or a cognitive behavioral therapy
(CBT) intervention called Managing Anxiety and Depression using Education and Skills (MADES). A total
of 100 subjects were randomized into the study. Length of hospital stay was assessed with a 1-way analysis
of variance. Depression, anxiety, and quality of life were assessed with mixed-model repeated measures
analyses.
Results: Overall, the intervention was feasible, and patients had a positive impression of the MADES. Patients
in the TAU group stayed longer in the hospital than did those in the MADES group (7.9 days 2.6 vs 9.2 days
3.5; P ¼ .049). Depressive symptoms increased at time of hospital discharge for the TAU group, whereas the
MADES group had a decrease in depressive symptoms at the time of discharge. Quality of life and anxiety symp-
toms improved in both groups at 3 to 4 weeks of follow-up. However, the MADES group had greater improve-
ments than did the TAU group.
Conclusions: This study demonstrated that brief, tailored CBT targeting preoperative depression and anxiety is
both feasible and acceptable for patients undergoing CABG surgery. Most important, this intervention improved
depressive and anxiety symptoms, as well as quality of life. Moreover, it reduced in-hospital length of stay. This
study found that a cognitive–behavioral intervention for patients undergoing CABG surgery for symptoms of
preoperative depression/anxiety is both feasible and acceptable. Most important, this intervention improved de-
pressive and anxiety symptoms, as well as quality of life. It also reduced in-hospital length of stay. (J Thorac
Cardiovasc Surg 2011;142:e109-15)Approximately 469,000 coronary artery bypass graft
(CABG) operations are performed annually in the United
States, making it one of the most commonly performed
invasive operations.1 Patients for whom CABG surgery is
recommended may incur significant psychological distress
as a result of both coronary artery disease (CAD) and the
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The Journal of Thoracic and Carsectional studies have examined the association between
psychological functioning and CABG surgery outcomes,
particularly with depression.2-4 A review of the literature
using MEDLINE and PsychINFO produced over 100
studies investigating this relationship. These studies
provide evidence for the following: depression occurs in
18% to 60% of patients with heart disease; it predicts
postoperative complications, longer physical and
emotional recovery, poorer quality of life, and increased
rates of cardiac events and mortality.2-6
Despite the important contribution of these studies, the
principal unanswered questions in this field remain primar-
ily treatment related.7,8 Although only a handful of clinical
trials examined the benefits of treating depression or
anxiety in CABG patients postoperatively,7,9-11 no
published clinical trials have specifically examined the
impact of cognitive–behavioral approaches in treating
depression or anxiety on CABG patients preoperatively.
A review of the literature indicated that only 2 clinical
trials have examined whether treating depressed heart
patients for depression postoperatively has any impactdiovascular Surgery c Volume 142, Number 3 e109
Abbreviations and Acronyms
BDI-II ¼ Beck Depression Inventory-II
CABG ¼ coronary artery bypass graft
CAD ¼ coronary artery disease
CBT ¼ cognitive behavioral therapy
MADES ¼ Managing Anxiety and Depression
using Education and Skills
MINI ¼ Mini International
Neuropsychological Interview
SF-12 ¼ 12-item Short Form Health Survey
STAI ¼ State–Trait Anxiety Inventory
TAU ¼ treatment as usual
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Don cardiovascular outcomes. SADHART (Sertraline Anti-
Depressant Heart Attack Trial) was a small safety study
that found a trend toward reduced cardiovascular
mortality and morbidity with selective serotonin reuptake
inhibitors but was too small and short to draw useful
conclusions.12 The ENRICHD (Enhancing Recovery in
Coronary Heart Disease) trial found that cognitive behav-
ioral therapy (CBT) after myocardial infarction had a mod-
est effect on depression13 but did not affect cardiac events
such as nonfatal infarction, death from any cause, and car-
diac death.
The current study examined the feasibility of a brief, tai-
lored CBT intervention, Managing Anxiety and Depres-
sion using Education and Skills (MADES), for treating
patients with CAD and symptoms of depression or anxiety
who have been scheduled to undergo CABG surgery. Fur-
thermore, the study assessed the impact of this intervention
on depression/anxiety symptoms and in-hospital length of
stay.METHODS
Participants
Institutional review board approval was obtained from the hospital facil-
ity as well as from the investigators’ University Human Subject’s Commit-
tee. This study was conducted in accordance with the Declaration of
Helsinki. Patients were recruited from a Veterans Affairs hospital between
February 2007 and May 2009. Patients signed informed consent forms and
were enrolled if they had clinically significant symptoms of depression
and/or anxiety according to the Beck Depression Inventory-II (BDI-II;
score  14) or the State–Trait Anxiety Inventory (STAI; score  40 on ei-
ther the State or Trait Scale), respectively14,15 These patients also had
a CAD diagnosis and were scheduled to undergo a first-time CABG oper-
ation without concomitant valve procedures. Subjects were excluded if
they had any of the following: serious medical illness other than CAD, psy-
chiatric instability (eg, suicidality), schizophrenia, bipolar disorder, active
alcoholism or substance abuse, severe cognitive impairment, noncardiac
illnesses with a poor 1-year prognosis, previous exposure to cognitive–be-
havioral treatment within the past year, or receiving ongoing psychothera-
peutic services. Of note, current use of psychotropic medications, such as
an antidepressant medication, was not an exclusion criterion, so long as the
patient has been taking the medication for at least 4 weeks. Recruitment ofe110 The Journal of Thoracic and Cardiovascular Sursubjects consisted of having a cardiothoracic surgeon and team (registered
nurses, nurse practitioners, and physician assistants) evaluate all potential
patients who were referred to undergo CABG surgery. Those who were
identified as candidates for the CABG and who had been scheduled to un-
dergo the operation in the next 4 to 10 days were further screened by the
principal investigator or a trained member on the study team. Patients
were told that the screening was to evaluate their mood and that they
may qualify for a research project that will be explained to them if they
meet the study’s eligibility criteria. Eligible patients had four 60-minute
sessions with the therapist for treatment of depression and anxiety symp-
toms. Figure 1 presents the flow of subjects through the study. A total of
513 patients were screened for eligibility from February 2007 to May
2009. Of those, 413 subjects were excluded owing to being ineligible
for the study. Thus, a total of 100 subjects were randomized into the study.
The sample consisted of mostly men (n ¼ 76; 78%) with an average age
of 63.6 years (SD ¼ 15.3). There was no significant difference between
subjects assigned to the MADES treatment and those assigned to treat-
ment as usual (TAU) on any of the demographic variables. The majority
of subjects were white (n ¼ 76, or 76%), 20% were African American,
and 4% were Hispanic American. In terms of marital status, 22% were
single, 58% were married, 5% were separated, and the remainder were
divorced or widowed. In regard to education level, 72% had completed
high school, 6% had greater than 12 years of education, and the remain-
der had less than 12 years of education. Regarding household income,
22% were in the range of $20,000 or less, 52% were in the range of
$20,001 to $40,000, 21% were in the range of $40,001 to $60,000, and
5% were in the range of $45,001 or greater.
On the basis of the Mini International Neuropsychological Interview
(MINI),16 subjects had a variety of comorbid psychiatric diagnoses that
included panic disorder (n ¼ 38), obsessive–compulsive personality disor-
der (n ¼ 2), social phobia (n ¼ 11), posttraumatic stress disorder (n ¼ 51),
bulimia nervosa (n ¼ 1), and adult attention-deficit/hyperactive disorder
(n ¼ 2). There were no significant differences between the groups at pre-
treatment on the measures of depression and anxiety (see Table 3).
Twenty patients enrolled in the study were receiving psychotropic medi-
cations. c2 analysis revealed that the proportion of patients receiving med-
ications did not differ significantly between groups, c2(1,97) ¼ 1.11,
P ¼ .291.
Procedures
Referred patients with a CAD diagnosis who have been scheduled to
undergo a CABG in the next week completed a consent for screening
that consisted of the BDI-II, STAI-Trait, 12-item Short Form Health
Survey (SF-12), and the MINI. Individuals who scored 14 or greater
on the BDI-II or 40 or greater on the STAI were randomly assigned
using a random numbers table to receive the TAU or a brief form of
CBT.
Baseline measures were completed at least 7 days before the scheduled
operation. Follow-up assessments were completed at the end of treatment
(posttest 1) and when patients came back for their 3- to 4-week follow-up
appointment with their cardiac team (posttest 2). Thus, the BDI-II and the
STAI-Trait inventories were administered in the last session of the treat-
ment while patients were still in the hospital. At the 3- to 4-week follow-
up, the BDI-II, STAI-Trait, and the SF-12 were administered. In addition,
patients in the intervention group completed a questionnaire about the cred-
ibility of the intervention at the end of the first session. At the end of the
fourth session, patients in the intervention group completed a measure of
treatment satisfaction.
Measures
Screening and outcome measures. The BDI-II and the STAI-
Trait were used to assess levels of anxiety and depression.14,15 MINI was
used to determine psychiatric diagnoses.16 Length of hospital stay, the
BDI-II, and the STAI-Trait scales scores were the primary outcomegery c September 2011
Potential Participants (n=513)
Enrollment 
Excluded (n=413) 
• BDI-2 or STAI too low 
(n=402) 
Psychotic disorder (n=1) 
Illness with poor prognosis 
(n=3) 
Prior exposure to CBT 
(n=2) 
Drug dependence (n=2) 
•
•
•
•
• Receiving ongoing  
psychotherapy (n=4) 
Randomization 
MADES (n=50) TAU (n=50) 
In-Hospital Follow-
up (n=48) 
In-Hospital Follow-
up (n=49) 
3-4 Weeks Follow-
up (n=48) 
3-4 Weeks Follow-
up (n=48) 
FIGURE 1. Participant enrollment, assignment, and follow-up. BDI-2, Beck Depression Inventory-II; STAI, State-Trait Anxiety Inventory; CBT, cognitive
behavioral therapy; MADES, Managing Anxiety and Depression using Education and Skills; TAU, treatment as usual.
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of each inventory are provided in Table 1.16-19
Intervention
The brief CBT intervention is called Managing Anxiety and Depression
using Education and Skills (MADES). It was developed by a team of experts
with knowledge in depression, anxiety, and CBT principles. MADES uses
a manualized approach to address the needs of patients who have CHD
with preoperative depression and/or anxiety. The MADES intervention con-
sisted of four 60-minute treatment sessions. Two clinical psychologists ad-
ministered the MADES intervention over the course of the study. All
treatment sessions were videotaped, and a random 20% were reviewed by
the lead investigator.Videotaped reviews indicatedadherenceandcompliance
with the protocol. Table 2 provides an overview of the MADES intervention.
Data Analysis
c2 and unpaired t tests were performed to evaluate potential confound-
ing group demographic and medical variables between the TAU group and
the MADES group. Demographics and preoperative data collected and an-
alyzed for each patient included age, gender, race, median household in-
come, New York Heart Association heart failure functional class, number
of affected vessels, and Comorbidity Index of Deyo and associates.20
The Comorbidity Index of Deyo and associates, adapted from the Charlson
Comorbidity Index, is designed to capture comorbid conditions recorded in
the inpatient setting using ICD-9-CM diagnosis and procedure codes.21
This index has been widely used in outcomes studies with administrative
datasets as the principal data source.22 Length of hospital stay was assessed
with a 1-way analysis of variance. The primary outcomes (BDI-II, STAI-The Journal of Thoracic and CarTrait, and SF-12) were assessed with mixed-model repeatedmeasures anal-
yses. Mixed models were specified with a between-subjects variable of
treatment group (1¼ intervention and 0¼ TAU), a within-subject variable
of time (0¼ baseline, 1¼ posttest 1, and 2¼ posttest 2), and a treatment by
time interaction. Maximum likelihood determined population parameters
for the fixed effects. All analyses were conducted with SPSS version 17
(SPSS, Inc, Chicago, Ill).
RESULTS
Sample Characteristics
c2 and t tests were used to examine potential differences
between the TAU and the MADES groups. Table 3 provides
descriptive statistics for the group-specific samples. In gen-
eral, the 2 groups were similar on demographic and medical
variables. Effect size estimates suggest that most of these
differences were very small in magnitude (range of coeffi-
cients, 0.016-0.253). The only variable that was signifi-
cantly different was diabetes with the TAU group having
more patients with diabetes than the MADES group. This
difference was moderate in magnitude (Cohen’s d¼ 0.443).Intervention Implementation
Of the 100 patients who entered the study, 3 patients did
not complete the intervention. One patient died during thediovascular Surgery c Volume 142, Number 3 e111
TABLE 1. Psychometric properties and descritions of instruments
Measures Cronbach alpha Description, psychometric properties
Beck Depression Inventory-II (BDI-II) .83 A 21- item, self-report measure. Scores of 14 or greater was used to indicate
significant symptoms of depression. The BDI-II has strong reliability and validity
with medically ill patients and has been found to be sensitive to change in
psychotherapy trials.18
State-Trait Anxiety Inventory (STAI) .81 A 20-item self-report measure of trait or dispositional anxiety. Scores of 40 or
greater were used to classify patients as having significant symptoms of anxiety.
The STAI-Trait has been validated in cardiopulmonary patients.19
Mini International Neuropsychological
Interview (MINI)
— A brief, semistructured diagnostic interview used to diagnose patients with
psychiatric disorders. The MINI has demonstrated adequate reliability and
validity for making DSM diagnoses.16
Short Form-12 Health Survey (SF-12) .79 The SF-12 scale is an abbreviated version of the Short Form-36 (SF-36).17 The
SF-12 is a self-report inventory that measures both the physical and mental health
and consists of 12 questions that assess 8 different areas: physical functioning,
role-physical, bodily pain, general health perception, vitality, social functioning,
role-emotional, and mental health. Higher values on the transformed 0 to 100
scale for each health domain indicate better health status.
DSM, Diagnostic and Statistical Manual of Mental Disorders.
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Dhospital stay. The other 2 patients dropped out of the study
(1 patient in each group). All the remaining 48 patients in
the MADES group received all 4 sessions of the interven-
tion. Overall, patients had a positive impression of the inter-
vention. At the end of the intervention, patients found the
intervention to be helpful in reducing symptoms of depres-
sion (mean ¼ 7.3; SD ¼ 1.2; range, 5-10) and anxiety
(mean ¼ 8.3, SD ¼ 0.9, range 6-10), and they reported
that they would recommend this intervention to a friend
(mean ¼ 7.1; SD ¼ 0.9; range, 7-10).TABLE 2. Overview of MADES therapy
Session
no.
Duration
(min) When Content
1 60 Before surgery Overview of study
Psychoeducation
(education about CAD,
surgery, depression/
anxiety, etc)
Overview of CBT Identify
concerns (generate
problem list)
2 60 Before surgery Review behavioral goals
Introduce cognitive strategies
3 60 Three days after
surgery
Review cognitive strategies
Review cognitive distortions
Continue to support and
encourage
4 60 Five days after
surgery
Review materials
Generate plan for continued
change
Continue to support and
encourage
MADES,Managing Anxiety and Depression using Education and Skills; CAD, coro-
nary artery disease; CBT, cognitive behavioral therapy.
e112 The Journal of Thoracic and Cardiovascular SurOutcome Evaluation
One-way analysis of variance was used to determine
whether the MADES group differs significantly from the
TAU group on length of hospital stay after CABG surgery.
There was a significant effect of treatment on in-hospital
length of stay: F(1,95) ¼ 3.97, P ¼ .049.
Two-way mixed design repeated-measures analysis of
variances (with independent measures on treatment and re-
peated measures on time) were used to assess change across
baseline and postbaseline scores on the BDI-II, SF-12, and
STAI-Trait inventories. Table 4 provides means and stan-
dard deviations for the outcome variables in the study. In
regard to the BDI-II, it was significant within group
main effect of time on BDI-II scores: F(2,196) ¼ 6.59,
P ¼ .002.
There was also a significant difference between-group ef-
fect indicating that mean BDI-II scores were significantly
different between those in the TAU and MADES groups:
F(1,98) ¼ 8.69, P ¼ .004. There was significant interaction
effect between treatment groups and time: F(2,196)¼ 5.31,
P¼ .006. The interaction between treatment group and time
on BDI-II scores is shown in Figure 2.
STAI-Trait was significant within-group main effect of
time on STAI-Trait scores: F(2,196) ¼ 59.6, P < .001.
Between-group effect of treatment was also a significant
indication that the mean STAI-Trait scores were signifi-
cantly different between those in the TAU and MADES
groups: F(1,98) ¼ 17.1, P<.001. There was a significant
interaction effect between treatment groups and time:
F(2,196) ¼ 11.4, P< .001. Figure 3 displays the interac-
tion between treatment group and time on STAI-Trait
scores.
Moreover, the SF-12, was significantly different in the
within-group main effect of time on SF-12 scores:gery c September 2011
TABLE 3. Descriptive statistics for TAU and MADES therapy groups
Variable
TAU
(n ¼ 49)
MADES
(n ¼ 48) P value Effect size*
Age (y) 64.2 (SD ¼ 11.9) 62.8 (SD ¼ 11.8) .562 .118
Gender (male) 79.6% 77.1%
Race .655 .092
White 38 (77.6%) 39 (81.2%)
Other 11 (22.4%) 9 (18.8%)
Median household income .479 .144
$1-$44,900 27 (55.1%) 23 (47.9%)
$45,000 or more 22 (44.9%) 25 (52.1%)
NYHA class
No. of affected vessels
2.88 (SD ¼ 0.4)
2.96 (SD ¼ 0.6)
2.92 (SD ¼ 0.4)
3.10 (SD ¼ 0.5)
.624
.215
.100
.253
Arrhythmias 12 (24.4%) 10 (20.1%) .662 .043
CPB time (min) 84.6 (SD ¼ 26.2) 91.6 (SD ¼ 31.4) .236 .242
Psychiatric medications 8 (16.3%) 12 (24.4%) .291 .107
Preoperative beta blockers 38 (77.5%) 41 (85.4%) .319 .101
Duration of ICU stay (h) 46.3 (SD ¼ 23.6) 48.9 (SD ¼ 20.3) .562 .118
Left ventricular ejection fraction (%) 49.1 (SD ¼ 12.9) 52.3 (SD ¼ 15.3) .267 .226
Deyo et al20 index 1.31 (SD ¼ 1.10) 1.29 (SD ¼ 1.08) .928 .018
Myocardial infarction 17 (34.7%) 17 (35.4%) .941 .016
Congestive heart failure 10 (20.4)% 11 (22.9%) .764 .061
Peripheral vascular disease 4 (8.2%) 3 (6.4%) .716y .074
Cerebrovascular disease 3 (6.1%) 2 (4.2%) .989y .089
Dementia 0 (0.0%) 0 (0.0%) — —
COPD 8 (16.3%) 6 (12.5%) .592 .101
Rheumatologic disease 1 (2.0%) 0 (0.0%) .320y .203
Peptic ulcer disease 0 (0.0%) 0 (0.0%) — —
Mild liver disease 0 (0.0%) 0 (0.0%) — —
Diabetes 20 (40.8%) 10 (20.8%) .033 .443
Diabetes chronic complications 2 (4.1%) 1 (2.1%) .570y .116
Hemiplegia or paraplegia 0 (0.0%) 0 (0.0%) — —
Renal disease 1 (2.0%) 0 (0.0%) .320y .203
Malignancy 0 (0.0%) 0 (0.0%) — —
Moderate/severe liver disease 0 (0.0%) 0 (0.0%) — —
Metastatic solid tumor 0 (0.0%) 0 (0.0%) — —
AIDS/HIV 0 (0.0%) 0 (0.0%) — —
TAU, Treatment as usual; MADES, Managing Anxiety and Depression using Education and Skills; SD, standard deviation; NYHA, New York Heart Association Classification;
CPB, cardiopulmonary bypass; ICU, intensive care unit; COPD, chronic obstructive pulmonary disease; AIDS/HIV, acquired immunodeficiency disease/human immunodefi-
ciency virus. *Cohen’s d statistics were calculated using pooled variance and adjusted for unequal sample sizes for continuous variables and phi coefficients were calculated
for dichotomous variables. yFisher exact test calculated for significance testing.
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DF(1,98) ¼ 68.8, P<.001. There was no significant effect
of treatment group indicating that mean SF-12 scores for
those in the MADES and TAU groups were in general
the same: F(1,98) ¼ 3.22, P ¼ .076. Also, there was noTABLE 4. Means and standard deviations for outcome variables
MADES
PRE1 POST1 POST2
M SD M SD M S
STAI-Trait 55.8 11.8 36.6 10.9 40.6 1
BDI-II 23.0 6.6 15.9 5.1 19.2
SF-12 37.1 9.7 — — 48.6 1
LOS — — 7.9 2.6 — —
MADES,Managing Anxiety and Depression using Education and Skills; TAU, treatment as
up; M, mean; SD, standard deviation; STAI, State-Trait Anxiety Inventory; BDI-II, Beck
inpatient stay.
The Journal of Thoracic and Carsignificant interaction effect between treatment groups
and time: F(1,98) ¼ .780, P ¼ .379. Figure 4 displays
the interaction between treatment group and time on
SF-12 scores.TAU
PRE1 POST1 POST2
D M SD M SD M SD
2.1 55.4 11.2 49.0 7.4 45.6 7.7
6.7 22.4 6.2 23.4 11.6 22.5 10.7
1.1 38.3 9.9 — — 52.6 11.3
— — 9.2 3.5 — —
usual; PRE1, baseline; POST1, in-hospital follow-up; POST2, 3 to 4 weeks of follow-
Depression Inventory-II; SF-12, Short Form-12 Health Survey scale; LOS, length of
diovascular Surgery c Volume 142, Number 3 e113
FIGURE 2. Time by treatment group interaction on Beck Depression
Inventory-II (BDI-II) scores. MADES, Managing Anxiety and Depression
using Education and Skills; TAU, treatment as usual.
FIGURE 4. Time by treatment group interaction on Short Form-12 Health
Survey (SF-12) scores. MADES,Managing Anxiety and Depression using
Education and Skills; TAU, treatment as usual.
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DDISCUSSION
CBT and psychoeducation approaches are considered
among the most robust and safe evidenced-based interven-
tions to treat depression and anxiety in psychology and psy-
chiatry, and they are among the most widely implemented
treatments. CBT for anxiety and depression disorders usu-
ally involves a combination of behavioral techniques such
as muscle relaxation and cognitive-restructuring techniques
aimed at reducing distorted cognitions and information pro-
cessing biases. CBT has been shown repeatedly to be
equally effective to antidepressant medications in reducing
depressive symptoms.23 A distinct advantage of CBT over
medications is that they generally produce more long-
lasting improvement with very low relapse rates.23
Moreover, despite the high prevalence of depression and
anxiety before CABG surgery, they are underrecognized
and undertreated in the medical populations in general
and among cardiovascular patients in particular.8 Under-
treatment of these disorders affects the quality of life, qual-
ity of medical care, and cost of health care utilization.24
This might be largely due to the difficulty in advocating
for the recognition and treatment of an additional condition
in patients hospitalized for cardiac disease, as well as over-FIGURE 3. Time by treatment group interaction on State-Trait Anxiety
Inventory-Trait (STAI-Trait) scores. MADES, Managing Anxiety and De-
pression using Education and Skills; TAU, treatment as usual.
e114 The Journal of Thoracic and Cardiovascular Surlap in symptoms (such as fatigue, decreased appetite, worry,
sleep difficulties, and changes in sexual desire).8 Neverthe-
less, even with appropriate training in assessment of depres-
sion, treating depression with traditional CBTapproaches is
a challenge. Traditional CBT approaches usually require
a longer period of time. This is particularly problematic in
surgical patients inasmuch as the period between informing
patients of the indication for CABG surgery to the actual
surgery is usually limited. Thus, we developed and tested
a brief, tailored CBT intervention called Managing Anxiety
and Depression using Education and Skills (MADES).
The results of the study suggested that the MADES inter-
vention, when initiated preoperatively, led to improvements
in both depressive and anxiety symptoms in patients under-
going CABG surgery, as well as improving patients’ quality
of life. It has also been shown that the intervention is both
feasible and acceptable for patients undergoing CABG sur-
gery. Moreover, MADES treatment reduced in-hospital
length of stay.
The low dropout ratewas a reflection of the feasibility and
acceptability of the study and may also be an indirect reflec-
tion of its efficacy and lack of adverse effects associatedwith
it. Of the 50 patients who were assigned to the MADES
group, only 1 patient dropped out of the study and did not
complete the intervention. In the TAU group, there was
also 1 patient who asked to be dropped from the study.More-
over, on the basis of self-reports, patients affirmed that the
intervention was helpful in reducing depression and anxiety
and that they would recommend the intervention to a friend.
Patients in the TAU group had higher BDI-II scores
(indicating higher depressive symptomatology) on their
posttest compared with their pretest assessment. On the
contrary, patients in the MADES group had lower BDI-II
scores on their posttest compared with their pretest assess-
ment. The finding that BDI-II scores actually increased on
the posttest assessment in the TAU group suggests that if
depressive symptoms go untreated, these symptoms could
actually be exacerbated after surgery. In addition,gery c September 2011
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Dimprovements in anxiety symptoms were reflected by sig-
nificant improvement in the STAI-Trait scores showing
significant interaction effect between treatment groups
and time.
Patients in the MADES group have lower length of hos-
pital stay than do patients in the TAU group. Specifically,
patients in the TAU group, on average, stayed an extra
day longer in the hospital than did patients in the MADES.
As the cost of inpatient hospitalization continues to in-
crease, this finding has both clinical and practical implica-
tions. For instance, the total cost associated with the
surgery and in-hospital stay is about $38,000 (about
$4000 per hospital day).25 Reducing hospitalization even
by 1 day will decrease cost by several thousand dollars
per patient. This will also reduce use of resources such as
hospital staff, equipment, and beds, which makes them
available for other patients in need of care.
Despite the positive findings of the study, there are several
limitations to consider. This study did not use multiple inter-
viewers to assess diagnostic reliability. However, diagnoses
weremade by an experienced clinician using theMINI. Sec-
ond, the majority of patients in both the MADES and TAU
groups had comorbid diagnoses. Thus, some caution is war-
ranted in the interpretation of the effect of the treatment of
depression or anxiety. On the other hand, this limitation can
also be viewed as increasing the external validity and gener-
alizablity of the study to real life clinical settings, given that
in clinical settings, comorbidity of psychiatric disorders is
more common than single morbidity.26 Third, no informa-
tion was obtained regarding the differences in pain medica-
tions between the TAU and the MADES groups at the time
that postoperative testing was conducted, which could influ-
ence the results of the study (ie, in-hospital and 3-4 weeks of
follow-up). Fourth, inasmuch as the study was not able to
blind the surgeons towhich group the patients were assigned
to, experimenter bias may be a threat to the internal validity
of this study. Fifth, this study was conducted with a popula-
tion of veterans; thus, the results of the study cannot be gen-
eralized to the civilian population. Finally, although pain
medications were assessed at the beginning of the study,
there were no pain medication assessments after surgery.
Thus, the results of the treatment may be due to an interac-
tional effect between pain medications and the MADES
intervention.
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